REFORM BIOLOGICS LLC has a total of 36 patent applications. It decreased the IP activity by 14.0%. Its first patent ever was published in 2015. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and Canada. Its main competitors in its focus markets biotechnology, pharmaceuticals and foods and drinks are UNITE DE RECH EN BIOLOG MOLECU, POSTERNAK SWIGEL DR and LI LUQING.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 11 | |
#2 | WIPO (World Intellectual Property Organization) | 7 | |
#3 | Canada | 5 | |
#4 | EPO (European Patent Office) | 5 | |
#5 | Republic of Korea | 4 | |
#6 | China | 2 | |
#7 | Brazil | 1 | |
#8 | Japan | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Foods and drinks | |
#4 | Macromolecular chemistry and polymers | |
#5 | Medical technology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Peptides | |
#3 | Enzymes | |
#4 | Microorganisms | |
#5 | Special macromolecular compounds | |
#6 | Syringes |
# | Name | Total Patents |
---|---|---|
#1 | Wuthrich Philip | 34 |
#2 | Soane David S | 29 |
#3 | Mahoney Robert P | 29 |
#4 | Greene Daniel G | 21 |
#5 | Moody Mark | 18 |
#6 | Naik Subhashchandra | 8 |
#7 | Tran Timothy | 7 |
#8 | Portilla Rosa Casado | 7 |
#9 | Mahoney Robert | 5 |
#10 | Soane David | 5 |
Publication | Filing date | Title |
---|---|---|
WO2021072050A1 | Excipient compounds for protein formulations | |
US2021113697A1 | Excipient compounds for protein formulations | |
WO2020112855A1 | Excipient compounds for protein processing | |
EP3761962A1 | Excipient compounds for protein formulations | |
WO2019036619A1 | Stabilizing excipients for therapeutic protein formulations | |
EP3582801A1 | Excipient compounds for protein processing | |
US2019054175A1 | Excipient compounds for protein processing | |
KR20190027878A | Stabilizing excipients for therapeutic protein preparations | |
US2017232103A1 | Excipient compounds for biopolymer formulations | |
WO2017070501A1 | Excipient compounds for biopolymer formulations | |
KR20170023114A | Viscosity-reducing excipient compounds for protein formulations |